HM Venture Partners — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Melodi Healthmelodihealth.comNov 2023
Melodi Health is developing Melodi Matrix, a product aimed at improving breast reconstruction outcomes after mastectomy.
FemTechHealthtechMedical DevicesMinneapolis, US
Matthew Hemsley(Director)Arikha Moses(Director)Robert S White(Director)Sarah Worrell(Executive Officer, Director)Kai Worrell(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.